We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IART market cap is 2.48B. The company's latest EPS is USD 0.8597 and P/E is 36.54.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 380.85M | 381.27M | 382.42M | 397.04M | 368.87M |
| Operating Income | 36.38M | 12.5M | 26.59M | 36.05M | 3.96M |
| Net Income | 24.23M | 4.18M | 19.5M | 19.83M | -3.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.52B | 1.37B | 1.54B | 1.56B | 1.54B |
| Operating Income | 93.76M | 151.37M | 197.23M | 238.92M | 111.53M |
| Net Income | 50.2M | 133.89M | 169.08M | 180.55M | 67.74M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.74B | 3.78B | 3.74B | 3.78B | 4.08B |
| Total Liabilities | 2.07B | 2.09B | 2.16B | 2.19B | 2.48B |
| Total Equity | 1.67B | 1.68B | 1.58B | 1.59B | 1.6B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.3B | 3.62B | 3.78B | 3.89B | 3.78B |
| Total Liabilities | 1.89B | 2.1B | 2.1B | 2.09B | 2.19B |
| Total Equity | 1.42B | 1.51B | 1.68B | 1.8B | 1.59B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 26.16M | 54.44M | 81.21M | 139.96M | 15.76M |
| Investing | -13.7M | -29.25M | -36.95M | -94.18M | -53.97M |
| Financing | -162.68M | -173.38M | -223.04M | -229.93M | 358.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 231.43M | 203.83M | 312.43M | 264.47M | 139.96M |
| Investing | -162.67M | -68.07M | -161.44M | -58.58M | -94.18M |
| Financing | -8.77M | 121.63M | -98.23M | -251.95M | -229.93M |
| Market Cap | 2.48B |
| Price to Earnings Ratio | 36.54 |
| Price to Sales Ratio | 1.61 |
| Price to Cash Ratio | 8.95 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 78.8M |
| Average Volume (1 week) | 730.14k |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | -31.04% |
| 52 Week High | 46.75 |
| 52 Week Low | 22.36 |
| Spread (Intraday) | 1.77 (5.47%) |
| Company Name | Integra LifeSciences Holdings Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.integralife.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
